CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.
Seyfrid M, Maich WT, Shaikh VM, Tatari N, Upreti D, Piyasena D, Subapanditha M, Savage N, McKenna D, Mikolajewicz N, Han H, Chokshi C, Kuhlmann L, Khoo A, Salim SK, Archibong-Bassey B, Gwynne W, Brown K, Murtaza N, Bakhshinyan D, Vora P, Venugopal C, Moffat J, Kislinger T, Singh S.
Seyfrid M, et al. Among authors: murtaza n.
J Immunother Cancer. 2022 Jan;10(1):e003289. doi: 10.1136/jitc-2021-003289.
J Immunother Cancer. 2022.
PMID: 35017149
Free PMC article.